Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Live Attenuated Varicella Vaccine in Adolescents and Adults
ChiCTR2300072153Phase 3Recruiting
- Sponsor
- Disease Control Center, Hubei
- Start
- Jun 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varicella vaccine live in chickenpox (8 arms), sponsored by Disease Control Center, Hubei. Primary endpoints: Antibody seroconversion rate, Antibody geometric mean titer and 1 more. Started Jun 2023; status: recruiting.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on ChiCTR2300072153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072153.